Renuell Intl, Inc. Distribution Agreement

EXHIBIT 10.7

Renuell Intl, Inc. Distribution Agreement

Amendment Two

THIS Amendment Two to that certain Distribution Agreement, ("Agreement") of December 29, 2011 by and between Regenetech, Inc., a corporation duly organized under the laws of the State of Texas, U.S.A., (hereinafter known as "RGT"), and Renuell Intl Inc. a Florida Corporation duly organized under the laws of State of Florida, U.S.A., (hereinafter known as "RII"), for and in the consideration expressed in the Agreement, and in this Amenment Two, agree as follows:

Use of AMA Laboratories, Inc., Final Report, dated February 22, 2012; AMA Ref. No.: MS11INUSE.M3547.REP.REG (hereinafter known as the "Report") . RGT hereby grants non-exclusive rights to RII to use the Report. RII shall submit, in writing, all uses of the Report to RGT for approval or rejection, prior to any uses of the Report. RGT may terminate this Amendment Two, at any time, and within its sole discretion by giving RII written notice. The Report may only be used by RII to further the purposes of the Agreement, and upon termination of the Agreement, RII shall cease and desist from any use of the Report in any manner. RII shall indemnify RGT, and its directors, officers, employees and agents, and defend and hold each of them, individually, or collectively, harmless from and against any and all claims, losses, damages, liabilities, costs, or expenses of any kind or nature (including, but not limited to, reasonable attorneys’ fees and expenses) in connection with RII’s use of, or reliance upon the Report, and from any and all claims, losses, damages, liabilities, costs, or expenses of any kind or nature (including, but not limited to, reasonable attorneys’ fees and expenses) arising out of, or related to this Amendment Two. RGT may supply AMA Laboratories, Inc. a copy of this Amendment Two.

There are no other changes to the Agreement.

IN WITNESS WHEREOF, the parties have caused this Amendment Two to the Agreement to be executed and effective as of May 7, 2012.

"RGT"
Regenetech, Inc.

By: _____________________
Name: Xxxx Xxxxxx
Title: President